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A B S T R A C T
Objectives: We aimed to analyze the outcomes of patients who underwent
vulvectomy with subsequent VeY fasciocutaneous ﬂap reconstruction.
Methods: All medical records of all patients who underwent vulvectomies with VeY fasciocutaneous ﬂap reconstruction from January 2007 to June 2016 were
retrospectively reviewed. Patient clinical and surgical data, demographics, and outcomes were abstracted.
Results: Of the 27 patients, 42 ﬂaps were transferred. A simple vulvectomy was performed in 8 (30%) patients, partial radical vulvectomy in 15 (56%), and radical
vulvectomy in 4 (15%). The median area of defect was 30 cm2. Minor wound separations occurred in 9 patients (33%). Infectious complications occurred in 4 patients
(15%); this included urinary tract infections in 2 (50%), postoperative fevers in 2 (50%), and sepsis in 1 (25%) patient with a UTI. There were no instances of ﬂap
necrosis, wound dehiscence, or wound infections. Black race was more likely to be associated with an infectious complication with 3 (75%) patients, compared to
white race with 1 (4%) patient (p < .01). The presence of diabetes was more likely to be associated with an infectious complication in 2 (67%) patients, compared to
1 (4%) in non-diabetic patients (p < .01). No other signiﬁcant association was found during analysis of demographics, medical comorbidities, vulvar pathology, or
surgical factors aﬀecting VeY fasciocutaneous ﬂap infectious complications or minor wound separations.
Conclusions: The use of a VeY fasciocutaneous advancement ﬂap for vulvar reconstruction is safe and associated with mostly minor complications. Infectious
complications were more frequently associated with diabetes, black race, and HIV.
1. Introduction
Vulvar cancer is a rare gynecologic malignancy that comprises only
3–5% of all gynecologic neoplasms.(Judson et al., 2006; Carramaschi
et al., 1999). In 2018, there will be an estimated 6190 new cases and
1200 deaths from vulvar cancer.(Siegel et al., 2018). Squamous cell
carcinoma (SCC) is the predominant tumor type and accounts for>
90% of all cases.(Del Pino et al., 2013; Lazzaro et al., 2010)
Vulvar cancer and other vulvar pathologies are usually treated with
an en bloc vulvectomy, due to the high rate of recurrence. Postoperative
dehiscence, lymphocysts, and lymphedema rates have been reported as
high as 64–85%.(Carramaschi et al., 1999). In recent years a modiﬁed
approach has been used to decrease morbidity. Primary closure is
possible, however tension placed on the site can result in extensive
tissue breakdown and prolonged healing. Additionally, the aesthetic
result can impair patient's sexual and urinary functions. Necrosis, de-
hiscence, and infections can all prolong hospitalization.
A variety of reconstructive techniques have been employed to re-
construct residual vulvectomy defects in an eﬀort to decrease post-
operative complications, length of hospital stay, and to improve patient
satisfaction.(Carramaschi et al., 1999; McCraw et al., 1976; Lin et al.,
1992). These reconstructive techniques include the use of skin grafts,
local skin ﬂaps, regional skin ﬂaps, and distant skin ﬂaps. Regional ﬂaps
utilize the tissue in the area of the defect but often do not about the
defect. They are mostly myocutaneous and thus, tend to be bulky. These
ﬂaps result in increased operating time and high complication rates.
(Carramaschi et al., 1999; McCraw et al., 1976; Chen et al., 1995).
Distant ﬂaps utilize tissue far from the defect. They can either be cre-
ated with a vascular pedicle in order to leave the vascular supply
anatomically connected, or harvested as free ﬂaps with the vascular
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supply being interrupted and then reconnected.
The VeY advancement ﬂap is a local fasciocutaneous ﬂap that in-
volves mobilizing the adjacent skin and underlying subcutaneous tissue
to cover the primary defect. The letter “V” represents the initial V-
shaped incision that is created along the adjacent skin and underlying
subcutaneous tissue that is mobilized over the primary vulvar defect.
The letter “Y” represents how the skin is closed, with the tail denoting
the primary closure of the harvested site. This technique can be used
when the donor site has enough laxity to allow appropriate mobiliza-
tion to cover the defect at the time of initial surgery.(Carramaschi et al.,
1999; Tateo et al., 1996; Benedetti Panici et al., 2014; Lee et al., 2006).
This is an ideal treatment as restoration can occur at the time of de-
molitive surgery and primary healing can occur. These ﬂaps may be
erythematous and edematous for weeks but should be in their ﬁnal form
at 3 to 6months. It is also beneﬁcial as similar skin characteristics can
be found in the local ﬂap. The aim of our study was to analyze the
outcomes of patients who underwent vulvectomy with subsequent VeY
fasciocutaneous ﬂap reconstruction from adjacent gluteal or medial
thigh folds for a variety of vulvar pathologies at a single institution.
2. Methods
2.1. Patient population
The medical records of all patients who underwent a vulvectomy
with VeY fasciocutaneous ﬂap reconstruction at Thomas Jeﬀerson
University Hospital (TJUH) from January 1, 2007 to June 1, 2016 were
retrospectively reviewed after obtaining IRB approval. Demographic,
surgical information, disease outcomes, and complications were ab-
stracted. Patients without adequate medical records were excluded. All
patients were given preoperative deep vein thrombosis prophylaxis
with heparin as well as preoperative antibiotics. They were placed in
dorsal lithotomy position, prepped with chlorahexadine and betadine,
and had a Foley catheter placed. A gynecologic oncologist performed
the ﬁrst portion of the surgery, which ranged from a simple vul-
vectomy, partial radical vulvectomy, or radical vulvectomy plus uni-
lateral or bilateral groin dissection, depending on pathology. A plastic
surgeon performed the second portion of the surgery, a VeY fasciocu-
taneous advancement ﬂap from the adjacent gluteal or medial thigh
folds. Unilateral or bilateral VeY ﬂap reconstruction was performed
based on the size of the tumor and defect after primary excision. The
wound was irrigated with antibiotic irrigation and the ﬂaps were in-
cised with a scalpel. The ﬂap was mobilized down to the muscular
fascia and elevated with undermining of the subcutaneous tissue. A JP
drain, if necessitated by the size of defect, was placed beneath the ﬂap
and brought out anteriorly through the skin. The wound was closed in
multiple layers with deep dermal sutures followed by a running sub-
cuticular closure in order to prevent the most amount of tension. This is
detailed in Figs. 1 and 2. Postoperatively, patients were allowed to
ambulate the morning after surgery. Sequential compression devices
were used throughout the surgery and postoperatively in the hospital to
prevent deep venous thrombosis. Prophylactic subcutaneous heparin
was administered every 8 h, starting on postoperative day 1 during the
hospital stay.
2.2. Statistics
Descriptive statistics were used to summarize the characteristics of
the patient population, surgical procedures, and surgical outcomes with
medians, ranges, and frequencies. The associations between demo-
graphics, medical comorbidities, type of vulvar pathology, or surgical
factors aﬀecting VeY fasciocutaneous ﬂap minor wound separations
and infectious complications were examined. t-tests were used to
compare means of continuous variables or Mann-Whitney to compare
Fig. 1. Creation of VeY Fasciocutaneous Flap.
A. Initial defect in blue.
B. Initial V-shaped skin incision is made adjacent to the defect. Subcutaneous tissue underlying V is undermined.
C. V-shaped skin is mobilized over the primary vulvar defect, is mobilized and medial edge closed.
D. Apex of the V is closed linearly. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 2. Radical vulvectomy with bilateral VeY Fasciocutaneous Advancement Flaps.
Initial defect prior to surgical intervention.
After resection of the lesion with marked ﬂaps to be excised.
Final appearance of bilateral ﬂaps in place.
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medians if data was skewed. Chi Square or Fishers Exact test as ap-
propriate were used for categorical variables. Data analysis was per-
formed with STATA version 12 (Stata-Corp LP, College Station, TX,
USA). Signiﬁcance was deﬁned as a P value< .05.
3. Results
3.1. Patient characteristics
During the study period from 2007 to 2016, 27 patients underwent
vulvectomies with a total of 42 V-Y fasciocutaneous ﬂap reconstructions
at TJUH. Table 1 details patient demographics. The median age of
patients was 69 years old, with a range of 25 to 93 years old. Twenty-
two (81%) patients were Caucasian and 5 (19%) were black. Medical
comorbidities included 3 (11%) patients with diabetes mellitus, 8
(30%) with hypertension, and 1 (4%) with HIV. Six patients (22%) were
current or previous smokers.
3.2. Surgical characteristics
As seen in Table 1, a simple vulvectomy was performed in 8 (30%)
patients, partial radical vulvectomy in 15 (56%), and radical vul-
vectomy in 4 (15%). Inguinofemoral lymph node dissections were
performed in 10 (37%) patients at the time of surgery. Median esti-
mated blood loss was 50mL and median total operative time was
179min (Table 2). Median length of stay was 3 days. The median area
of defect was 30 cm2. Drains at the site of vulvar reconstruction were
used in 24 (89%) patients and a wound vacuum was placed prophy-
lactically in 1 (4%) patient who had multiple prior surgeries. Drains
were left in place for a median of 10 days, until the patient's post-
operative visit with the plastic surgeon.
3.3. Stage of disease and tumor characteristics
Of the 27 patients, 21 (78%) had surgery for cancer (Table 1). Of
these cancers, 17 (81%) were squamous cell carcinoma (SCC), 2 were
due to Paget's Disease, 1 was a dermatoﬁbrosarcoma, and 1 was a
metastatic endometrial adenocarcinoma. Four (24%) of the SCC were
recurrent at the time of surgery. The majority of the SCCs were Stage I,
with 3 (18%) that were Stage Ia and 9 (53%) that were Stage Ib. The
remaining patient had a Stage IIIb SCC of the vulva. Grade 2 disease
was found in 7 (41%) patients.
3.4. Complications and disease outcomes
Primary wound healing complications occurred in 9 patients (33%)
and included minor wound separations, or local scar defects. These are
detailed in Table 3. Infectious complications occurred in 4 (15%) pa-
tients: 2 (50%) had urinary tract infections (UTI), 2 (50%) had post-
operative fevers, one due to atelectasis and one due to an unknown
cause, and 1 (25%) of the patients with a UTI was found to be septic.
Foleys were left in place for a median of 1 day postoperatively. There
were no instances of ﬂap necrosis, wound dehiscence, or surgical site
infections. There were no recurrences. One patient later died, unrelated
to her disease. Four patients had chemoradiation: 2 in the neoadjuvant
setting and 2 in the adjuvant setting. One patient had adjuvant vaginal
brachytherapy alone.
3.5. Associations of infectious complications and minor wound separations
Of the four patients with infectious complications, 3 (75%) were
black and 1 (25%) Caucasian (See Table 4). One (25%) patient smoked
and 2 (50%) had diabetes. Black race was associated with an infectious
complication in 3 patients (75%), compared to white race with 1 pa-
tient (4%) (p < .01). Additionally, the presence of diabetes was more
likely to be associated with an infectious complication in 2 (67%) of the
diabetic patients, compared to 1 (4%) of the non-diabetic patients
(p < .01). HIV was also found to be associated with infectious com-
plications (p < .01), with the 1 (100%) patient with HIV having an
infectious complication. No association was found between other de-
mographics, medical comorbidities, type of vulvar pathology, or sur-
gical factors aﬀecting VeY fasciocutaneous ﬂap infectious complica-
tions or minor wound separations. We had no instances of ﬂap necrosis,
wound dehiscence, or wound infections.
Table 1
Demographics and disease characteristics.
Median (range)
Age (years) 69 (25–93)
BMI (kg/m2) 29 (18–51)
N=27
n(%)
Race
White 22 (81)
Black 5 (19)
Comorbidities
Diabetes 3 (11)
Hypertension 8 (30)
HPV 2 (7)
Lichen sclerosis 5 (19)
Hidradenitis suppurativa 1 (4)
HIV 1 (4)
Smoking 6 (22)
Type of Surgery
Simple Vulvectomy 8 (30)
Partial Radical Vulvectomy 15 (56)
Radical Vulvectomy 4 (15)
Groin LN Dissection 10 (37)
Anatomic location
Anterior/Lateral Vulva 17 (63)
Perineum/Posterior Vulva 10 (37)
Laterality of surgery
Unilateral 12 (44)
Bilateral 15 (56)
Malignant
Cancer 21(78)
Benign 6 (22)
Pathology
Squamous Cell Carcinoma 17 (63)
Paget's 2 (7)
Dermatoﬁbrosarcoma 1 (3)
Endometrial Adenocarcinoma 1 (3)
Bartholin's cyst 1 (3)
Hidradenitis Suppurativa 1 (3)
Chronic abscess/ﬁstula 1 (3)
VIN III 1 (3)
Vaginal Smooth Muscle Tumor 1 (3)
Subepithelial Lymphangiectasia 1 (3)
Stage of SCC (n=17)
Ia 3 (18)
Ib 9 (53)
II 0 (0)
IIIa 0 (0)
IIIb 1 (5.9)
IIIc 0 (0)
IV 0 (0)
Recurrent 4 (24)
Grade of SCC (n=17)
1 5 (29)
2 7 (41)
3 5 (29)
Radiation
Neoadjuvant 2 (10)
Adjuvant 3 (18)
Kg/m2= kilogram/m2
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4. Discussion
This study highlights the overall feasibility and safety of using a
VeY fasciocutaneous advancement ﬂap from adjacent tissue for
primary vulvar reconstruction for patients with vulvar pathologies.
Demolitive vulvar surgery can be extensive and reconstruction is im-
portant in improving quality of life and reducing complications. The use
of a VeY fasciocutaneous advancement ﬂap for vulvar reconstruction is
safe and associated with minor complications in most situations.
Minor wound separations, dehiscence, and necrosis have been re-
ported in the literature, however, in our patient population, there were
only 9 local scar defects which all healed conservatively.(Lazzaro et al.,
2010). Infectious complications, including urinary tract infections and
fevers postoperatively only occurred in 4 patients, with one patient
developing sepsis from the UTI. We found diabetes, black race, and HIV
to be associated with infectious complications. The presence of both
diabetes and HIV have been shown to lead to infectious complication.
(Dryden et al., 2015; Knapp, 2013). It is, however, unclear why black
race led to an increase in infectious complications. We also did not ﬁnd
any demographic or surgical factors associated with minor wound se-
parations. Given the small number of patients and complications, a
larger sample size would be useful to further investigate these asso-
ciations.
In the literature, there is a low rate of dehiscence after vulvectomy
with VeY fasciocutaneous advancement ﬂaps. In one series of 17 glu-
teal fold ﬂaps in 9 patients, small wound disruptions occurred in 3
patients, which healed conservatively. There was no necrosis. (Lee
et al., 2006). In a case series of 8 patients with 16 gluteal fold VeY
advancement ﬂaps, 1 patient had marginal ﬂap necrosis. (Lazzaro et al.,
2010). In another case series of 21 patients, with 36 V-Y advancement
ﬂaps, local scar defect was noted in 16 patients (76%). The defects
were<10 cm in 10 patients. No necrosis of the ﬂaps were observed.
(Conri et al., 2016). Additionally, in another case series of 5 patients
with 7 V-Y advancement ﬂaps, one patient had partial dehiscence after
surgery. (Nakamura et al., 2010)
Conri et al. found VeY suprafascial gluteal advancement ﬂaps to be
safe options for a reliable reconstruction of vulvar defects despite ASA
score, age, or BMI.(Conri et al., 2016). Their cohort of patients was
operated and cared for in the French healthcare system and the patients
remained in the hospital until local scar defects were healed to allow for
Table 2
Surgical information.
N=27
n (%)
Drains Used 24 (89)
Wound Vac Used 1 (4)
Median (range)
Time Drains Used (days) 10 (2–27)
Time Foley Left in (days) 1 (0–7)
Area of Defect (cm2) 30 (6–131)
EBL (mL) 50 (5–400)
Total Operative Time (minutes) 179 (50–315)
Hospital Stay (days) 3 (1–7)
cm2= centimeter2, mL=milliliters, min=minute.
Table 3
Surgical complications.
N=27
n (%)
Minor wound separations 9 (33)
Postoperative fever 2 (7)
Sepsis 1 (4)
Urinary Tract Infection 2 (7)
Lymphocele 0 (0)
VTE/PE 0 (0)
Surgical Site infection 0 (0)
Dehiscence 0 (0)
Flap necrosis 0 (0)
Recurrence 0 (0)
Death 1 (4)
Table 4
Analysis of minor infectious complications.
Minor Infectious Complications
n=4
n (%)
No infectious complications
n=23
n (%)
P value⁎
Demographics
Black Race 3 (75) 2 (9) < 0.01
Age (years, median (range)) 67 (44–74) 69 (25–93) 0.84
BMI (kg/m2, median (range)) 26 (19–31) 29 (18–51) 0.25
Comorbidities
Smoker 1 (25) 5 (22) 0.89
Diabetes 2 (50) 1 (4) < 0.01
Hypertension 2 (50) 6 (26) 0.94
HIV 1 (25) 0 (0) 0.02
Lichen Sclerosis 1 (25) 4 (17) 0.72
Hidradenitis 0 (0) 1 (4) 0.67
HPV 1 (25) 1 (4) 0.15
Surgical factors
Radical Vulvectomy 2 (50) 2 (9) 0.85
Use of drains 4 (100) 20 (87) 0.44
OR Time (minutes, median (range)) 219 (195–238) 169 (50–315) 0.17
EBL (mL, median (range)) 125 (20–250) 50 (5–400) 0.28
Area of defect (cm2, median (range)) 29 (23–61) 36 (6–131) 1.00
Pathology
Cancer 3 (75) 18 (78) 0.89
kg/m2= kilogram/m2, mL=milliliters, cm2= centimeter2.
⁎ For continuous variables, a t-test was performed unless data was not normally distributed when a Mann-Whitney test performed. For categorical
data Chi Square or Fishers Exact test were used as appropriate.
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inpatient postoperative nursing care. They commented that tension free
repairs spent half the time in the hospital.(Conri et al., 2016). In our
cohort of patients in the U.S., median hospital stay was 3 days. All local
scar defects were managed as outpatients and healed without need for
reoperation.
One limitation of this series of cases is the lack of controls for
comparison. However, in a recent study, the use of a VeY gluteal fold
advancement ﬂap for large vulvectomy sites (> 4 cm) showed a sta-
tistically signiﬁcant reduction in wound dehiscence compared to de-
molitive only surgeries.(Benedetti Panici et al., 2014). Compared to
patients with large resections, the wound dehiscence rate was reduced
from 40% to 10.3%. Median post-operative hospital stay was reduced to
3 days and 90% had good primary healing. Only 3 patients had com-
plications, none with necrosis.(Benedetti Panici et al., 2014). Another
study looked at patients who either had a traditional extensive vul-
vectomy and inguinal lymphadenectomy with either primary closure of
the wound, local advancement ﬂaps, or skin grafts compared to patients
followed prospectively with a modiﬁed triple incision radical vul-
vectomy and inguinal lymphadenectomy followed by immediate VeY
ﬂaps from the upper inner thighs.(Carramaschi et al., 1999). The
perineal and inguinal dehiscence rates in the traditional approach were
68.4% and 78.9% compared to 10.5% and 36.8% in the modiﬁed ap-
proach.(Carramaschi et al., 1999)
A recent systematic review looked at the complication rates and
feasibility of using reconstructive ﬂaps after vulvovaginal malig-
nancies.(Di Donato et al., 2017). They included 24 studies and found
the majority of ﬂaps were either advancement ﬂaps or transpositional
ﬂaps with similar complication rates: 26.7% vs 22.3%, respectively. Of
the 11 advancement ﬂap studies they included, only 165 patients were
included, further solidifying the need for further research related to
this technique.(Di Donato et al., 2017). Finally, a retrospective single
institution series looked at 234 patients undergoing a VeY advance-
ment ﬂap compared to 128 undergoing a lotus petal ﬂap (LPF) after
demolitive surgery for vulvar malignancies.(Confalonieri et al., 2017)
Wound infection, ﬂap dehiscence, or local ﬂap ischemia only occurred
in 21% of the VeY ﬂaps and 13% of the LPF ﬂaps. There was no
statistically signiﬁcant diﬀerence between the two groups and the
study concluded both are valid techniques for reconstruction.
(Confalonieri et al., 2017)
When deciding between advancement or transposition fasciocuta-
neous ﬂaps, the size and aesthetic results should be taken into con-
sideration.(Di Donato et al., 2017; Confalonieri et al., 2017). Both have
low complication rates however expertise in surgical dissection of the
vessels is necessary for transposition ﬂaps. Some institutions prefer
transposition ﬂaps due to the aesthetic results with less scarring com-
pared to the VeY. (Confalonieri et al., 2017). Moderate to large sized
defects often require an advancement ﬂap as less tension is placed on
the wound.(Di Donato et al., 2017)
Overall, our study supports the ease and feasibility of using VeY
advancement ﬂaps in the immediate reconstruction of vulvar defects. It
is a simple and easy procedure with few complications in most cases.
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